Global Antipsychotic Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder.
Scope of the Report:
This report focuses on the Antipsychotic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
During 2016, the second-generation antipsychotic drugs segment dominated the antipsychotic drugs market with the highest market shares. These drugs are preferred over first-generation antipsychotic drugs because they involve lesser side effects and are highly efficient in the treatment of various mental disorders. The adoption of these drugs is high because they reduce EPSE, controls symptoms, and maintains the normal levels of prolactin. This segment yields a high prescription value that in turn, will drive growth in the segment during the forecasted period.
The worldwide market for Antipsychotic Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Antipsychotic Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antipsychotic Drugs, with sales, revenue, and price of Antipsychotic Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antipsychotic Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Antipsychotic Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Antipsychotic Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Scope of the Report:
This report focuses on the Antipsychotic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
During 2016, the second-generation antipsychotic drugs segment dominated the antipsychotic drugs market with the highest market shares. These drugs are preferred over first-generation antipsychotic drugs because they involve lesser side effects and are highly efficient in the treatment of various mental disorders. The adoption of these drugs is high because they reduce EPSE, controls symptoms, and maintains the normal levels of prolactin. This segment yields a high prescription value that in turn, will drive growth in the segment during the forecasted period.
The worldwide market for Antipsychotic Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- AstraZeneca
- Eli Lilly
- GlaxoSmithKline
- Johnson & Johnson
- Actavis Generics
- Alkermes
- Bristol-Myers Squibb
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- First Antipsychotic Drugs
- Second Antipsychotic Drugs
- Third Antipsychotic Drugs
- Schizophrenia
- Bipolar Disorder
- Unipolar Depression
- Dementia
- Others
Chapter 1, to describe Antipsychotic Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antipsychotic Drugs, with sales, revenue, and price of Antipsychotic Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antipsychotic Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Antipsychotic Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Antipsychotic Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Antipsychotic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 First Antipsychotic Drugs
1.2.2 Second Antipsychotic Drugs
1.2.3 Third Antipsychotic Drugs
1.3 Market Analysis by Applications
1.3.1 Schizophrenia
1.3.2 Bipolar Disorder
1.3.3 Unipolar Depression
1.3.4 Dementia
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Antipsychotic Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Antipsychotic Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Antipsychotic Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Antipsychotic Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Actavis Generics
2.5.1 Business Overview
2.5.2 Antipsychotic Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Actavis Generics Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Alkermes
2.6.1 Business Overview
2.6.2 Antipsychotic Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Alkermes Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bristol-Myers Squibb
2.7.1 Business Overview
2.7.2 Antipsychotic Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bristol-Myers Squibb Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL ANTIPSYCHOTIC DRUGS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global Antipsychotic Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antipsychotic Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Antipsychotic Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Antipsychotic Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL ANTIPSYCHOTIC DRUGS MARKET ANALYSIS BY REGIONS
4.1 Global Antipsychotic Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Antipsychotic Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Antipsychotic Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Antipsychotic Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Antipsychotic Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antipsychotic Drugs Sales and Growth Rate (2013-2018)
4.5 South America Antipsychotic Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antipsychotic Drugs Sales and Growth Rate (2013-2018)
5 NORTH AMERICA ANTIPSYCHOTIC DRUGS BY COUNTRIES
5.1 North America Antipsychotic Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Antipsychotic Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Antipsychotic Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Antipsychotic Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Antipsychotic Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Antipsychotic Drugs Sales and Growth Rate (2013-2018)
6 EUROPE ANTIPSYCHOTIC DRUGS BY COUNTRIES
6.1 Europe Antipsychotic Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Antipsychotic Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Antipsychotic Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antipsychotic Drugs Sales and Growth Rate (2013-2018)
6.3 UK Antipsychotic Drugs Sales and Growth Rate (2013-2018)
6.4 France Antipsychotic Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Antipsychotic Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Antipsychotic Drugs Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC ANTIPSYCHOTIC DRUGS BY COUNTRIES
7.1 Asia-Pacific Antipsychotic Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Antipsychotic Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Antipsychotic Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Antipsychotic Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Antipsychotic Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Antipsychotic Drugs Sales and Growth Rate (2013-2018)
7.5 India Antipsychotic Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antipsychotic Drugs Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA ANTIPSYCHOTIC DRUGS BY COUNTRIES
8.1 South America Antipsychotic Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Antipsychotic Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Antipsychotic Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antipsychotic Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Antipsychotic Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Antipsychotic Drugs Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA ANTIPSYCHOTIC DRUGS BY COUNTRIES
9.1 Middle East and Africa Antipsychotic Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antipsychotic Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Antipsychotic Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antipsychotic Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Antipsychotic Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Antipsychotic Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Antipsychotic Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Antipsychotic Drugs Sales and Growth Rate (2013-2018)
10 GLOBAL ANTIPSYCHOTIC DRUGS MARKET SEGMENT BY TYPE
10.1 Global Antipsychotic Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Antipsychotic Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Antipsychotic Drugs Revenue and Market Share by Type (2013-2018)
10.2 First Antipsychotic Drugs Sales Growth and Price
10.2.1 Global First Antipsychotic Drugs Sales Growth (2013-2018)
10.2.2 Global First Antipsychotic Drugs Price (2013-2018)
10.3 Second Antipsychotic Drugs Sales Growth and Price
10.3.1 Global Second Antipsychotic Drugs Sales Growth (2013-2018)
10.3.2 Global Second Antipsychotic Drugs Price (2013-2018)
10.4 Third Antipsychotic Drugs Sales Growth and Price
10.4.1 Global Third Antipsychotic Drugs Sales Growth (2013-2018)
10.4.2 Global Third Antipsychotic Drugs Price (2013-2018)
11 GLOBAL ANTIPSYCHOTIC DRUGS MARKET SEGMENT BY APPLICATION
11.1 Global Antipsychotic Drugs Sales Market Share by Application (2013-2018)
11.2 Schizophrenia Sales Growth (2013-2018)
11.3 Bipolar Disorder Sales Growth (2013-2018)
11.4 Unipolar Depression Sales Growth (2013-2018)
11.5 Dementia Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 ANTIPSYCHOTIC DRUGS MARKET FORECAST (2018-2023)
12.1 Global Antipsychotic Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Antipsychotic Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Antipsychotic Drugs Market Forecast (2018-2023)
12.2.2 Europe Antipsychotic Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Antipsychotic Drugs Market Forecast (2018-2023)
12.2.4 South America Antipsychotic Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Antipsychotic Drugs Market Forecast (2018-2023)
12.3 Antipsychotic Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Antipsychotic Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Antipsychotic Drugs Market Share Forecast by Type (2018-2023)
12.4 Antipsychotic Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Antipsychotic Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Antipsychotic Drugs Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Antipsychotic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 First Antipsychotic Drugs
1.2.2 Second Antipsychotic Drugs
1.2.3 Third Antipsychotic Drugs
1.3 Market Analysis by Applications
1.3.1 Schizophrenia
1.3.2 Bipolar Disorder
1.3.3 Unipolar Depression
1.3.4 Dementia
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Antipsychotic Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Antipsychotic Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Antipsychotic Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Antipsychotic Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Actavis Generics
2.5.1 Business Overview
2.5.2 Antipsychotic Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Actavis Generics Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Alkermes
2.6.1 Business Overview
2.6.2 Antipsychotic Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Alkermes Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bristol-Myers Squibb
2.7.1 Business Overview
2.7.2 Antipsychotic Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bristol-Myers Squibb Antipsychotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL ANTIPSYCHOTIC DRUGS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global Antipsychotic Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antipsychotic Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Antipsychotic Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Antipsychotic Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL ANTIPSYCHOTIC DRUGS MARKET ANALYSIS BY REGIONS
4.1 Global Antipsychotic Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Antipsychotic Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Antipsychotic Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Antipsychotic Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Antipsychotic Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antipsychotic Drugs Sales and Growth Rate (2013-2018)
4.5 South America Antipsychotic Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antipsychotic Drugs Sales and Growth Rate (2013-2018)
5 NORTH AMERICA ANTIPSYCHOTIC DRUGS BY COUNTRIES
5.1 North America Antipsychotic Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Antipsychotic Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Antipsychotic Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Antipsychotic Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Antipsychotic Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Antipsychotic Drugs Sales and Growth Rate (2013-2018)
6 EUROPE ANTIPSYCHOTIC DRUGS BY COUNTRIES
6.1 Europe Antipsychotic Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Antipsychotic Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Antipsychotic Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antipsychotic Drugs Sales and Growth Rate (2013-2018)
6.3 UK Antipsychotic Drugs Sales and Growth Rate (2013-2018)
6.4 France Antipsychotic Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Antipsychotic Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Antipsychotic Drugs Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC ANTIPSYCHOTIC DRUGS BY COUNTRIES
7.1 Asia-Pacific Antipsychotic Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Antipsychotic Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Antipsychotic Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Antipsychotic Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Antipsychotic Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Antipsychotic Drugs Sales and Growth Rate (2013-2018)
7.5 India Antipsychotic Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antipsychotic Drugs Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA ANTIPSYCHOTIC DRUGS BY COUNTRIES
8.1 South America Antipsychotic Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Antipsychotic Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Antipsychotic Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antipsychotic Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Antipsychotic Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Antipsychotic Drugs Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA ANTIPSYCHOTIC DRUGS BY COUNTRIES
9.1 Middle East and Africa Antipsychotic Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antipsychotic Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Antipsychotic Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antipsychotic Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Antipsychotic Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Antipsychotic Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Antipsychotic Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Antipsychotic Drugs Sales and Growth Rate (2013-2018)
10 GLOBAL ANTIPSYCHOTIC DRUGS MARKET SEGMENT BY TYPE
10.1 Global Antipsychotic Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Antipsychotic Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Antipsychotic Drugs Revenue and Market Share by Type (2013-2018)
10.2 First Antipsychotic Drugs Sales Growth and Price
10.2.1 Global First Antipsychotic Drugs Sales Growth (2013-2018)
10.2.2 Global First Antipsychotic Drugs Price (2013-2018)
10.3 Second Antipsychotic Drugs Sales Growth and Price
10.3.1 Global Second Antipsychotic Drugs Sales Growth (2013-2018)
10.3.2 Global Second Antipsychotic Drugs Price (2013-2018)
10.4 Third Antipsychotic Drugs Sales Growth and Price
10.4.1 Global Third Antipsychotic Drugs Sales Growth (2013-2018)
10.4.2 Global Third Antipsychotic Drugs Price (2013-2018)
11 GLOBAL ANTIPSYCHOTIC DRUGS MARKET SEGMENT BY APPLICATION
11.1 Global Antipsychotic Drugs Sales Market Share by Application (2013-2018)
11.2 Schizophrenia Sales Growth (2013-2018)
11.3 Bipolar Disorder Sales Growth (2013-2018)
11.4 Unipolar Depression Sales Growth (2013-2018)
11.5 Dementia Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 ANTIPSYCHOTIC DRUGS MARKET FORECAST (2018-2023)
12.1 Global Antipsychotic Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Antipsychotic Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Antipsychotic Drugs Market Forecast (2018-2023)
12.2.2 Europe Antipsychotic Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Antipsychotic Drugs Market Forecast (2018-2023)
12.2.4 South America Antipsychotic Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Antipsychotic Drugs Market Forecast (2018-2023)
12.3 Antipsychotic Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Antipsychotic Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Antipsychotic Drugs Market Share Forecast by Type (2018-2023)
12.4 Antipsychotic Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Antipsychotic Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Antipsychotic Drugs Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Antipsychotic Drugs Picture
Table Product Specifications of Antipsychotic Drugs
Figure Global Sales Market Share of Antipsychotic Drugs by Types in 2017
Table Antipsychotic Drugs Types for
Figure Antipsychotic Drugs Picture
Table Product Specifications of Antipsychotic Drugs
Figure Global Sales Market Share of Antipsychotic Drugs by Types in 2017
Table Antipsychotic Drugs Types for
